lobbying_activities: 2814412
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2814412 | 540a8aed-28ad-4f99-a8b4-342165c8efe9 | Q2 | OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC | 30212 | JAZZ PHARMACEUTICALS INC. | 2022 | second_quarter | BUD | Appropriations issues, FDA and DEA issues | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2022-07-05T13:23:00-04:00 |